Physician profile
Adam Michael Becker
NPI 1891093456
$10,247.21
in general payments reported to CMS, 2019-2025
52 companies · $2,154 in 2025
The $2,154 reported for 2025 was more than what 81% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,039 · 2020: $729 · 2021: $1,273 · 2022: $1,051 · 2023: $1,529 · 2024: $1,472 · 2025: $2,154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,062 · Education: $92.03.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,062.44 |
| Education | $92.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $1,216.99 | 2019-2020 | |
| C. R. Bard, INC. & Subsidiaries | $1,041.98 | 2020-2025 | Bard Urinary Drainage Bag, Magic3 Go Intermittent Urinary Catheter |
| Astellas Pharma US INC | $925.72 | 2019-2024 | Myrbetriq, Xtandi |
| Pfizer INC. | $580.98 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $491.49 | 2023-2025 | Gemtesa, Orgovyx |
| Endo Pharmaceuticals INC. | $473.97 | 2019-2023 | Xiaflex, Aveed |
| Janssen Biotech, INC. | $424.63 | 2019-2025 | Erleada |
| Abbvie INC. | $339.83 | 2019-2025 | Botox |
| Rochester Medical Corporation | $262.78 | 2021-2022 | |
| Medtronic, INC. | $259.24 | 2021-2024 | Interstim |
| Becton, Dickinson and Company | $253.03 | 2024 | Bard Urinary Drainage Bag |
| Boston Scientific Corporation | $246.67 | 2019-2025 | General - Therapies |
| 180 Medical, INC. | $232.46 | 2019-2025 | |
| Medtronic USA, INC. | $225.82 | 2019-2020 | |
| Procept Biorobotics Corporation | $219.21 | 2024-2025 | Aquabeam System |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $217.36 | 2020-2025 | Prolaris |
| Antares Pharma, INC. | $207.96 | 2020-2023 | Xyosted, Nocdurna, Tlando |
| Merck Sharp & Dohme LLC | $197.02 | 2021-2024 | Keytruda, Welireg, Lynparza |
| Blue Earth Diagnostics | $191.81 | 2019-2025 | Posluma |
| Ethicon US, LLC | $162.14 | 2024-2025 | Vistaseal, Evarrest, Surgicel Nu-Knit |
| Coloplast Corp | $161.53 | 2019-2024 | Altis |
| Histosonics, INC. | $160.00 | 2025 | |
| Tolmar, INC. | $155.43 | 2023-2024 | |
| Allergan, INC. | $149.27 | 2019-2021 | |
| Axonics, INC. | $129.67 | 2020-2022 | |
| Edap Technomed INC | $123.00 | 2024 | |
| Valencia Technologies Corporation | $103.26 | 2025 | Ecoin Device Kit |
| Teleflex LLC | $90.83 | 2021-2023 | Urolift |
| Urogen Pharma, INC. | $87.75 | 2023-2025 | Jelmyto |
| Progenics Pharmaceuticals, INC. | $86.21 | 2022-2024 | |
| Novartis Pharmaceuticals Corporation | $83.84 | 2020-2025 | |
| Olympus America INC. | $72.40 | 2025 | Itind System |
| Tolmar Pharmaceuticals, INC. | $71.38 | 2021-2022 | |
| Koelis INC. | $67.91 | 2023-2024 | |
| Myovant Sciences INC. | $67.41 | 2021-2022 | |
| Urovant Sciences INC | $65.06 | 2021-2022 | |
| Accord Healthcare, INC. | $63.61 | 2022-2023 | |
| Immunitybio, INC. | $55.27 | 2025 | |
| Sun Pharmaceutical Industries INC. | $44.17 | 2022-2023 | Yonsa |
| Bayer Healthcare Pharmaceuticals INC. | $33.43 | 2021 | |
| Convatec INC. | $28.15 | 2021 | |
| Calyxo, INC. | $21.19 | 2024 | Cvac Aspiration System |
| Hollister Incorporated | $20.72 | 2023 | Vapro Plus Pocket, Infyna Chic |
| Amgen INC. | $19.10 | 2019 | |
| Alnylam Pharmaceuticals INC. | $17.65 | 2023 | Givlaari |
| Janssen Pharmaceuticals, INC | $17.11 | 2023 | Xarelto |
| Ferring Pharmaceuticals INC. | $16.89 | 2019 | |
| Dentsply Ih INC. | $16.35 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $13.79 | 2025 | Exparel, Iovera |
| Kowa Pharmaceuticals America, INC. | $13.14 | 2022 | |
| Sagent Pharmaceuticals | $11.22 | 2021 | |
| Travere Therapeutics, INC. | $9.38 | 2025 | Thiola |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Becker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.